Update information

Update information

November 2016: A footnote about 2 MHRA drug safety alerts was added to recommendations in section 1.6 covering angiotensin-converting enzyme (ACE) inhibitors. These alerts cover ACE inhibitor use during pregnancy and breastfeeding.

This guideline updates and replaces NICE clinical guideline 34 (published June 2006). NICE clinical guideline 34 updated and replaced NICE clinical guideline 18 (published in 2004). Recommendations are marked as [2004], [2004, amended 2011], [2006], [2008], [2009], [2010] or [2011].

  • [2004] indicates that the evidence has not been updated and reviewed since 2004

  • [2004, amended 2011] indicates that the evidence has not been updated and reviewed since 2004 but a small amendment has been made to the recommendation

  • [2006] indicates that the evidence has not been updated and reviewed since 2006

  • [2008] applies to recommendations from 'Lipid modification' (NICE clinical guideline 67), published in 2008

  • [2009] applies to recommendations from 'Medicines adherence' (NICE clinical guideline 76), published in 2009

  • [2010] applies to recommendations from 'Hypertension in pregnancy' (NICE clinical guideline 107), published in 2010

  • [2011] indicates that the evidence has been reviewed and the recommendation has been updated or added.

ISBN: 978-1-4731-2195-9

  • National Institute for Health and Care Excellence (NICE)